Bank of Montreal’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,762
| Closed | -$172K | – | 3551 |
|
|
2025
Q1 | $172K | Buy |
5,762
+1,515
| +36% | +$46.3K | ﹤0.01% | 2773 |
|
|
2024
Q4 | $122K | Buy |
4,247
+33
| +0.8% | +$1.09K | ﹤0.01% | 2900 |
|
|
2024
Q3 | $161K | Sell |
4,214
-754
| -15% | -$26.9K | ﹤0.01% | 3106 |
|
|
2024
Q2 | $163K | Sell |
4,968
-79
| -2% | -$2.74K | ﹤0.01% | 3072 |
|
|
2024
Q1 | $201K | Buy |
+5,047
| New | +$177K | ﹤0.01% | 3049 |
|
|
2022
Q2 | – | Sell |
-11,850
| Closed | -$239K | – | 4141 |
|
|
2022
Q1 | $239K | Buy |
11,850
+1,001
| +9% | +$18.9K | ﹤0.01% | 3341 |
|
|
2021
Q4 | $212K | Sell |
10,849
-191,331
| -95% | -$3.73M | ﹤0.01% | 2938 |
|
|
2021
Q3 | $4.02M | Buy |
202,180
+5,375
| +3% | +$116K | ﹤0.01% | 1738 |
|
|
2021
Q2 | $4.82M | Buy |
196,805
+17,385
| +10% | +$402K | ﹤0.01% | 1630 |
|
|
2021
Q1 | $4.13M | Sell |
179,420
-24,991
| -12% | -$594K | ﹤0.01% | 1439 |
|
|
2020
Q4 | $4.33M | Sell |
204,411
-28,278
| -12% | -$552K | ﹤0.01% | 1478 |
|
|
2020
Q3 | $4.92M | Sell |
232,689
-4,867
| -2% | -$87.8K | ﹤0.01% | 1215 |
|
|
2020
Q2 | $4.07M | Buy |
237,556
+2,936
| +1% | +$57.5K | ﹤0.01% | 1266 |
|
|
2020
Q1 | $3.67M | Sell |
234,620
-17,606
| -7% | -$363K | ﹤0.01% | 1135 |
|
|
2019
Q4 | $5.19M | Buy |
252,226
+179,888
| +249% | +$3M | ﹤0.01% | 1330 |
|
|
2019
Q3 | $830K | Sell |
72,338
-47,263
| -40% | -$540K | ﹤0.01% | 2171 |
|
|
2019
Q2 | $1.57M | Buy |
+119,601
| New | +$1.6M | ﹤0.01% | 1831 |
|
|
2019
Q1 | – | Sell |
-946
| Closed | -$16K | – | 4379 |
|
|
2018
Q4 | $16K | Buy |
946
+211
| +29% | +$3.61K | ﹤0.01% | 3716 |
|
|
2018
Q3 | $11K | Sell |
735
-5,873
| -89% | -$104K | ﹤0.01% | 3896 |
|
|
2018
Q2 | $157K | Buy |
6,608
+254
| +4% | +$6.25K | ﹤0.01% | 2882 |
|
|
2018
Q1 | $162K | Buy |
6,354
+3,993
| +169% | +$95.1K | ﹤0.01% | 2731 |
|
|
2017
Q4 | $44K | Hold |
2,361
| – | – | ﹤0.01% | 3301 |
|
|
2017
Q3 | $25K | Hold |
2,361
| – | – | ﹤0.01% | 3445 |
|
|
2017
Q2 | $30K | Hold |
2,361
| – | – | ﹤0.01% | 3386 |
|
|
2017
Q1 | $24K | Sell |
2,361
-6,292
| -73% | -$93.5K | ﹤0.01% | 3307 |
|
|
2016
Q4 | $143K | Buy |
8,653
+8,453
| +4,227% | +$140K | ﹤0.01% | 2660 |
|
|
2016
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 3751 |
|
|
2016
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 3887 |
|
|
2016
Q1 | $4K | Buy |
+200
| New | +$3.63K | ﹤0.01% | 3842 |
|
Other funds holding COLL
RCMNY
EAM
Bank of Montreal's COLL Position: Q2 2025 in Review
Bank of Montreal sold out of Collegium Pharmaceutical (COLL) in Q2 2025, closing a stake of 5,762 shares — an estimated $172K sold.
Bank of Montreal first reported a position in COLL in Q1 2016 and held it in 29 quarters. The position peaked at $5.19M in Q4 2019. 223 funds tracked by Wall St. Rank hold COLL as of Q2 2025.
- Bank of Montreal reported no remaining Collegium Pharmaceutical position as of Q2 2025 after selling out during the quarter.
- Bank of Montreal sold 5,762 Collegium Pharmaceutical shares in Q2 2025, an estimated $172K.
- Bank of Montreal first reported a position in Collegium Pharmaceutical in Q1 2016 and held it in 29 quarters.
- Bank of Montreal's Collegium Pharmaceutical position peaked at $5.19M in Q4 2019.
- 223 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2025.
Based on Bank of Montreal's 13F filing for Q2 2025, filed 5 Aug 2025.